Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleLaboratory Studies

Preparation, Biodistribution and Dosimetry of Copper-64-Labeled Anti-Colorectal Carcinoma Monoclonal Antibody Fragments 1A3-F(ab′)2

Carolyn J. Anderson, Sally W. Schwarz, Judith M. Connett, P. Duffy Cutler, Li Wu Guo, Carl J. Germain, Gordon W. Philpott, Kurt R. Zinn, Douglas P. Greiner, Claude F. Meares and Michael J. Welch
Journal of Nuclear Medicine May 1995, 36 (5) 850-858;
Carolyn J. Anderson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally W. Schwarz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith M. Connett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Duffy Cutler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Wu Guo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl J. Germain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon W. Philpott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt R. Zinn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas P. Greiner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claude F. Meares
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Welch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 36, Issue 5
May 1, 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preparation, Biodistribution and Dosimetry of Copper-64-Labeled Anti-Colorectal Carcinoma Monoclonal Antibody Fragments 1A3-F(ab′)2
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preparation, Biodistribution and Dosimetry of Copper-64-Labeled Anti-Colorectal Carcinoma Monoclonal Antibody Fragments 1A3-F(ab′)2
Carolyn J. Anderson, Sally W. Schwarz, Judith M. Connett, P. Duffy Cutler, Li Wu Guo, Carl J. Germain, Gordon W. Philpott, Kurt R. Zinn, Douglas P. Greiner, Claude F. Meares, Michael J. Welch
Journal of Nuclear Medicine May 1995, 36 (5) 850-858;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preparation, Biodistribution and Dosimetry of Copper-64-Labeled Anti-Colorectal Carcinoma Monoclonal Antibody Fragments 1A3-F(ab′)2
Carolyn J. Anderson, Sally W. Schwarz, Judith M. Connett, P. Duffy Cutler, Li Wu Guo, Carl J. Germain, Gordon W. Philpott, Kurt R. Zinn, Douglas P. Greiner, Claude F. Meares, Michael J. Welch
Journal of Nuclear Medicine May 1995, 36 (5) 850-858;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial Pathogens
  • Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET
  • Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System
  • In vivo Evaluation of 177Lu- and 67/64Cu-Labeled Recombinant Fragments of Antibody chCE7 for Radioimmunotherapy and PET Imaging of L1-CAM-Positive Tumors
  • PET Imaging of Oncogene Overexpression Using 64Cu-Vasoactive Intestinal Peptide (VIP) Analog: Comparison with 99mTc-VIP Analog
  • In Vivo Evaluation of Pretargeted 64Cu for Tumor Imaging and Therapy
  • Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy
  • High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
  • Radiotherapy and Dosimetry of 64Cu-TETA-Tyr3-Octreotate in a Somatostatin Receptor-positive, Tumor-bearing Rat Model
  • High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
  • Google Scholar

More in this TOC Section

  • Potassium and Thallium Uptake in Dog Myocardium
  • Kinetics of Technetium-99m-Teboroxime in Reperfused Nonviable Myocardium
  • Assessment of Cancer Recurrence in Residual Tumors after Fractionated Radiotherapy: A Comparison of Fluorodeoxyglucose, L-Methionine and Thymidine
Show more Laboratory Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire